phytic acid and deferoxamine

phytic acid has been researched along with deferoxamine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bandy, B; Davison, AJ1
Avenard, G; Chassaigne, M; Girot, R; Hurel, C; Nicolau, C; Ropars, C; Teisseire, B1
Bandy, B; Davison, AJ; Moon, J; Walter, PB1
Davidsson, L; Fidler, MC; Hurrell, RF; Walczyk, T1
Becker, HH; Dopp, E; Lohani, M; Poser, I; Rahman, Q; Schiffmann, D; Weiss, DG; Yadav, S1
Aust, AE; Baldys, A1

Trials

1 trial(s) available for phytic acid and deferoxamine

ArticleYear
Iron absorption from fish sauce and soy sauce fortified with sodium iron EDTA.
    The American journal of clinical nutrition, 2003, Volume: 78, Issue:2

    Topics: Adult; Anemia, Iron-Deficiency; Biological Availability; Deferoxamine; Diet; Edetic Acid; Female; Ferric Compounds; Ferritins; Fish Oils; Food, Fortified; Glycine max; Humans; Intestinal Absorption; Iron Isotopes; Iron, Dietary; Nutritional Status; Phytic Acid

2003

Other Studies

5 other study(ies) available for phytic acid and deferoxamine

ArticleYear
Interactions between metals, ligands, and oxygen in the autoxidation of 6-hydroxydopamine: mechanisms by which metal chelation enhances inhibition by superoxide dismutase.
    Archives of biochemistry and biophysics, 1987, Volume: 259, Issue:2

    Topics: Adenosine Diphosphate; Catalase; Chelating Agents; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Hydroxydopamines; Ligands; Metals; Oxidation-Reduction; Oxidopamine; Oxygen; Phytic Acid; Superoxide Dismutase

1987
Improved oxygen delivery to tissues and iron chelator transport through the use of lysed and resealed red blood cells: a new perspective on Cooley's anemia therapy.
    Annals of the New York Academy of Sciences, 1985, Volume: 445

    Topics: Animals; Blood Transfusion; Chelating Agents; Deferoxamine; Erythrocyte Aging; Erythrocyte Transfusion; Hematopoiesis; Hemoglobins; Iron; Oxygen; Phytic Acid; Swine; Thalassemia

1985
Reaction of oxygen with 6-hydroxydopamine catalyzed by Cu, Fe, Mn, and V complexes: identification of a thermodynamic window for effective metal catalysis.
    Archives of biochemistry and biophysics, 2001, May-01, Volume: 389, Issue:1

    Topics: Adenosine Diphosphate; Bromides; Buffers; Catalysis; Copper; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Iron; Ligands; Manganese; Osmolar Concentration; Oxidation-Reduction; Oxidopamine; Oxygen; Phytic Acid; Sodium Compounds; Thermodynamics; Vanadium

2001
Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor.
    Mutation research, 2004, Apr-11, Volume: 559, Issue:1-2

    Topics: Acetylcysteine; Asbestos, Crocidolite; Asbestos, Serpentine; Chelating Agents; Deferoxamine; Epithelial Cells; Free Radical Scavengers; Humans; Kinetochores; Lysine; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagenesis; Phytic Acid; Superoxide Dismutase; Thiourea

2004
Role of iron in inactivation of epidermal growth factor receptor after asbestos treatment of human lung and pleural target cells.
    American journal of respiratory cell and molecular biology, 2005, Volume: 32, Issue:5

    Topics: Asbestos; Asbestos, Crocidolite; Carcinogens; Cell Line; Cytochalasin B; Cytochalasin D; Deferoxamine; Dose-Response Relationship, Drug; Endocytosis; ErbB Receptors; Humans; Iron; Iron Chelating Agents; Lung; Mineral Fibers; Phosphorylation; Phytic Acid; Receptor, ErbB-2

2005